Mammalian STE20-like kinase 1 (Mst1) is the mammalian homologue of Drosophila Hippo, a major inhibitor of cell proliferation in Drosophila. It ubiquitously encodes serine threonine kinase that belongs to the family of protein kinases related to yeast STE20, and is involved in cell proliferation, apoptosis, oncogenesis, and organ growth. Recent studies have shown that Mst1 has tumor-suppressor function, and the deletion or mutation of Mst1 is reported to be associated with tumorigenesis. To investigate the effect of overexpression of Mst1 on the growth of human liver cancer cell line HepG2 cells and the sensitivity to cisplatin in vitro, here we constructed recombinant eukaryotic expression vector pEGFP-N1-Mst1 containing Mst1 gene, and transiently transfected into HepG2 cells. The effects of Mst1 overexpression on the cell proliferation and apoptosis, the phosphorylation status of Yes-associated protein, and the mRNA transcript levels of connective tissue growth factor (CTGF), amphiregulin (AREG), and birc5 (Survivin) were determined. Results showed that overexpression of Mst1 inhibited cell proliferation, induced apoptosis of HepG2 cells, promoted YAP (Ser127) phosphorylation, and downregulated the mRNA expression of CTGF, AREG, and Survivin. We also investigated the relationship between the expression and cleavage of Mst1 and cisplatin-induced cell death. We found that Mst1 overexpression could induce cisplatin chemosensitivity, and cisplatin could promote the cleavage of Mst1 without affecting the expression of Mst1. Overall, our results indicated that Mst1 might be a promising anticancer target.
Introduction
Live cancer (LC) is a digestive system cancer, the fifth most common malignant neoplasm worldwide and third most frequent cause of cancer-related death due to its highest mortality rate and recurrence rate [1] . Despite multimodal therapy, including surgery, chemotherapy, and radiotherapy, the curative effect on LC patients is not as good as anticipated and the prognosis remains poor [2] . Therefore, novel therapeutic schemes to complement or replace the existing modalities for treating LC are required. Gene therapy, which is characterized by an experimental therapeutic strategy with high efficiency, high specify, and high targeting, has been shown to have bright prospect [3] .
Mammalian STE20-like kinase 1 [Mst1, also named serine threonine kinase 4 (STK4) and kinase responsive to stress 2 (KRS2)] and Mst2 are 59 kDa class II germinal centre (GC) kinases that share 76% identity in amino acid sequence [4] and are the closest mammalian homologs of the Drosophila Hippo protein kinase. Mice lacking either Mst1 or Mst2 were viable and fertile, but those lacking both of them were not. Mice developed massive hepatomegaly and hepatocellular carcinoma (HCC) when both Mst1 and Mst2 are liver-specific double knockout. Therefore, a single functional copy of Mst1 or Mst2 is necessary and sufficient for normal mouse development and they can substitute each other in the most essential functions in a redundant manner and serve as critical HCC tumor suppressors [5] [6] [7] . Mst1 is a serine threonine kinase, which regulates cell growth, proliferation, apoptosis, and organ size [8] . The activation of Mst1 kinase can be regulated by phosphorylation, autophosphorylation, dephosphorization, caspase cleavage, dimerization, and cofactor preference. Activated Mst1 has pro-apoptotic function via activating C-Jun N-terminal kinase and p38 mitogen-activated protein kinase (p38MAPK), phosphorylating histone 2B (Ser14), histone H2AX (Ser139), forkhead box O 3 (FOXO3) (Ser207) and FOXO (Ser212), promoting the acetylation of p53 (Lys382), and interacting with RAS association domain family 1A [8] [9] [10] .
Of note, the activity of Mst1/2 is able to affect nuclear and cytoplasmic localization of Yes-associated protein (YAP) and Tafazzin (TAZ) [11, 12] , the mammalian Yorkie orthologs, which are the primary effectors of the mammalian Hippo
signaling pathway [13] [14] [15] [16] [17] . Hippo signaling pathway was first discovered in Drosophila. Yorkie's actions are proproliferative and antiapoptotic, and elimination of Yorkie is epistatic to loss of function of all of the upstream elements [18] . Hippo is the central component of this antiproliferative pathway that as a negative regulator of the oncogenic transcriptional co-activator, Yorkie, which can bind to the adaptor protein Salvador/Shar-pei, phosphorylates the Lats/ Warts kinase and the non-catalytic polypeptide Mats (Mob as tumor suppressor), then phosphorylates and inhibits Yorkie, by promoting its binding to 14-3-3 and nuclear exit [13] . When Hippo signaling is attenuated, Yorkie phosphorylation is reduced or absent, leading to its nuclear localization, binding to the sequence-specific DNA-binding protein scalloped and regulation of target genes. So the loss of Hippo function results in a Yorkie-dependent accelerated proliferation, resistance to apoptosis, and massive organ overgrowth [19, 20] . The Drosophila Hippo signaling pathway is highly conserved over evolutionary time, and the mammalian pathway has been implicated in regulating cell contact inhibition, organ size, and tumorigenesis [21, 22] . YAP as a candidate oncogene is amplified and constitutively activated in many human cancers [13, [23] [24] [25] [26] [27] [28] . Overexpression of an activated and nuclear localized form of YAP increased mouse liver size, which ultimately resulted in HCC [13, 15] . In mouse liver, combined Mst1/2 deficiency in the liver resulted in loss of inhibitory Ser127 phosphorylation of the YAP1, massive overgrowth, and HCC; however, re-expression of Mst1 in HCC-derived cell lines promoted YAP1 Ser127 phosphorylation and inactivation and abrogated their tumorigenicity, which indicated that Mst1 had tumor-suppressor function, and the deletion or mutation of Mst1 was closely related to the tumor [6] .
To investigate the biological effects of the overexpression of Mst1 gene in human HepG2 cells in vitro, we constructed a recombinant eukaryotic expression plasmid containing Mst1 gene fused with enhanced green fluorescence protein (EGFP) gene. We found that delivery of the Mst1 gene promoted HepG2 cells apoptosis. Moreover, Mst1 overexpression could potentiate the antitumor effect of cisplatin against HepG2 cells. It will be helpful for the development of novel gene therapy approaches for cancer treatment.
Materials and Methods
Cell lines and cell culture HepG2 cells cultured in Dulbecco's modified Eagle's medium medium (Solarbio, Beijing, China) plus 10% fetal calf serum (TransGen Biotech, Beijing, China), 2 mM L-glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin (all reagents were from Gibco BRL Life Technologies, Gaithersburg, USA). Cell lines were grown in a humidified incubator at 378C in 5% CO 2 atmosphere, and kept free from mycoplasma contamination using plasmocin (Invitrogen, Carlsbad, USA).
Plasmid construction
The vectors [pEGFP-N1-Mst1 and pEGFP-N1 (Clontech, Mountain View, USA)] used in this study contain human cytomegalovirus (CMV) immediate early promoter. Polymerase chain reaction (PCR) used Mst1-length forward primer: 5 0 -TCAAGCTTCGAATTctgcacGCCACCATGGAGACGGT ACAGCTGAG-3 0 ; and Mst1-length reverse primer: 5 0 -CT CACCATGGTGGCGaccggtCCGAAGTTTTGTTGCCGTC TCT-3 0 . The purified PCR product and transfer vector were digested, respectively, with the two enzymes, PstI and AgeI (New England Biolabs, Massachusetts, USA), at 378C for 30 min. The enzyme-digested product was purified again with the EasyPure quick gel DNA extraction kit (TransGen Biotech) and ligated using In-Fusion TM PCR cloning kit (Clontech) at 258C for 15 min, then at 428C for 15 min under conditions that permitted the existence of the corresponding adhesive ends. The ligated product was used to transfect Escherichia coli DH5a (TransGen Biotech). Then the growing positive colonies were picked out and gently mixed with Luria-Bertani broth containing kanamycin/neomycin resistance (Kan r ). The positive clones were screened by colony PCR using universal primers CMV-forward (5 0 -TCTAAA-AGCTGCGGAATTGT-3 0 ) and Mst1-segment reverse (5 0 -ATAGCTCTGGTTTTCGGAAT-3 0 ), and the corresponding plasmids were extracted using the EndoFree plasmid kit (TransGen Biotech). Finally, the insert was confirmed by PCR as designed above and sequencing analysis with universal primers CMV-forward and pEGFP-N-3 (5 0 -CGTCGCCGTCCAGCTCGACCAG-3 0 ).
Plasmid transfection
The plasmids were transfected into HepG2 cells using PolyJet TM in vitro DNA transfection reagent (Cat. #SL100688; SignaGen, Rockville, USA) according to the manufacturer's protocol. We got five groups in the experiments: control group (without any treatment); negative control group (transiently transfected with empty vector pEGFP-N1, named HepG2-vect); experimental group (transiently transfected with recombinant vector pEGFP-N1-Mst1, named HepG2-Mst1); positive control group [treated with 20 mg/ml cisplatin (DDP) for 24 h, named HepG2-DDP]; and combination group (transiently transfected with empty vector pEGFP-N1 or recombinant vector pEGFP-N1-Mst1 and treated with 20 mg/ml DDP for 24 h, named HepG2-vect þ DDP or HepG2-Mst1 þ DDP), respectively.
Cell proliferation analysis
Cell growth was determined by 3-(4,5-imethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (Sigma, Mst1 overexpression effects the growth of HepG2 and the sensitivity to cisplatin St Louis, USA). Briefly, 1 Â 10 4 cells were seeded into a 96-well plate in quadruplicate for each condition one day before transfection. MTT reagent (20 ml) was added to each well at 5 mg/ml and incubated for another 4 h at 378C. The formazan crystals formed by viable cells were then dissolved in 150 ml dimethyl sulfoxide (Solarbio) and measured at 490 nm for the absorbance (A) values. The cell inhibition rate was calculated as follows: inhibition rate ¼ [(light absorption of the control group 2 light absorption of the experimental group)/light absorption of the control group] Â 100%.
Hoechst 33342 staining HepG2 cells were seeded in the 12-well plates at 1 Â 10 5 cells/well one day before transfection. A total of 500 ml of Hoechst 33342 (Beyotime, Haimen, China) was added to each well and incubated for 30 min at 378C in dark. Hoechst-stained nuclei were observed by using a fluorescence microscope (Olympus, Tokyo, Japan). A total of 500 cells from five random high-power fields were counted. The percent of apoptosis was expressed as ratio of apoptotic cells to total cells.
Real-time quantitative PCR
Total RNA from each cell was isolated using Trizol reagent (TransGen Biotech) according to the manufacturer's protocol. The RNA samples were treated with DNase I (Sigma), quantified, and reverse transcribed into cDNA using the TransScript first-strand cDNA synthesis SuperMix (TransGen Biotech). Real-time quantitative PCR was performed using SYBR w Premix Ex Taq TM II (Tli RNase H Plus) (TaKaRa, Dalian, China) in the ABI PRISM w 7500 real-time PCR system (Applied Biosystems, Foster City, USA). The primer sequences used are shown in Table 1 , and all primers were taken from the PrimerBank website (http://pga.mgh.harvard.edu/primerbank/). PCR specificity was examined by analyzing the melting curves. The data were analyzed using the comparative threshold cycle method.
Western blot analysis
HepG2 cells were washed with phosphate buffered saline (PBS) and lysed with radio immunoprecipitation assay (RIPA) cell lysis reagent containing proteinase and phosphatase inhibitors (Solarbio) at 48C for 30 min. Cell extracts were centrifuged at 12,000 g for 20 min at 48C, and the supernatants containing total proteins were mixed with an equal volume of 5 Â sodium dodecyl sulfate (SDS) loading buffer. Samples were heated at 958C for 5 min, separated by 12% gel, and then electrotransferred onto 0.22 mm PVDF membrane. The membranes were blocked in Tris-buffered saline and Tween 20 (TBST) containing 5% skimmed milk and incubated overnight with the primary antibody [obtained from Cell Signaling Technology (Beverly, USA)] specific for Mst1 (Cat. #3682, 1 : 300), YAP (Cat. #4912, 1 : 300), phospho-YAP (Ser127) (Cat. #4911, 1 : 300), or caspase-3 (Cat. #9662, 1 : 300). And then the secondary horseradish peroxidaseconjugated AffiniPure goat anti-rabbit lgG(H þ L) or the secondary horseradish peroxidase-conjugated AffiniPure goat anti-mouse lgG(H þ L) (1 : 10,000, ZSGB-BIO, Beijing, China) was added. An anti-b-actin monoclonal antibody (1 : 1000, ZSGB-BIO) was used as an internal control. The intensity of the western blot bands was quantified using ImageJ 1.4.3.67 Launcher Symmetry software (NIH, Bethesda, USA). The protein relative level was calculated as follows: protein relative level ¼ (gray scale ratio between the target gene product bands and the b-actin protein bands in the experimental group)/(gray scale ratio between the target gene product bands and the b-actin protein bands in the control group).
Apoptosis assay
To examine cell apoptosis, monoplast suspension was prepared in each experimental group. All samples were stained with an Annexin V-FITC/PI apoptosis assay kit (MultiSciences, Hangzhou, China) according to the instruction manual, and analyzed with a FACScalibur flow cytometer (BectonDickinson, Franklin Lakes, USA).
Statistical analysis
Results are expressed as the mean + SD. Data were compared by one-way analysis of variance (with post hoc Turkey's honestly significant difference test) or unpaired Student's t-tests using SPSS 11.5. P , 0.05 was considered significant.
Results
Effect of overexpression of Mst1 on human HepG2 hepatoma cells growth and apoptosis To examine the effect of Mst1 overexpression on HepG2 cells, the pEGFP-N1-Mst1 recombinant plasmid [ Fig. 1(A) ] was constructed by ligating the enzyme-digested products of pEGFP-N1 and Mst1 PCR product verified by 1% agarose gel electrophoresis analysis [ Fig. 1(B) ]. The recombinant plasmid was validated by colony PCR [ Fig. 1(C) ] and DNA sequencing [ Fig. 1(D) ], and then transiently transfected into HepG2 cells. The efficiency of transfection was 70% displayed by EGFP after transfected for 48 h using a fluorescence microscope (Fig. 2) , and the overexpression of fusion protein Mst1-EGFP was confirmed by western blot analysis [ Fig. 3(A) ]. MTT assays revealed that cell growth was significantly inhibited in pEGFP-N1-Mst1-vector transfected cells and 20 mg/ml DDP-treated cells compared with pEGFP-N1 vector-transfected cells, and the inhibition rate was in a time-dependent manner [ Fig. 4(A) , a].
Mst1 overexpression effects the growth of HepG2 and the sensitivity to cisplatin Furthermore, a greater antiproliferative effect of DDP was observed when treated with 20 mg/ml DDP [ Fig. 4(A), a] . We used annexin-V/PI staining to assess apoptosis and found that cell apoptosis was induced in pEGFP-N1-Mst1 vector-transfected cells or 20 mg/ml DDP-treated cells [ Fig. 4(B), c,d ] compared with control group [Fig. 4(B) , a] and transfected with pEGFP-N1 [ Fig. 4(B), b] . Moreover, after treatment with DDP [ Fig. 4(B) , e], the apoptosis rate of the pEGFP-N1-Mst1 vector-transfected HepG2 cells was higher than that of either transfected with pEGFP-N1-Mst1 Mst1 overexpression effects the growth of HepG2 and the sensitivity to cisplatin only or treated with 20 mg/ml DDP only. In addition, Hoechst 33342 staining verified that apoptotic rate was elevated to 1.5 folds compared with controls in pEGFP-N1-Mst1 vector-transfected cells and 2.0 folds over that in pEGFP-N1-Mst1 vector-transfected cells treated with DDP (Fig. 5) . These data indicated that overexpression of Mst1 could inhibit cell proliferation and promote apoptosis of human HepG2 hepatoma cells.
Overexpression of Mst1 promoted YAP phosphorylation and downregulated the expression of CTGF, AREG, and Survivin Levels of total YAP1 polypeptide were increased following Mst1/2 inactivation, whereas YAP1 mRNA level was unchanged [6] . To gain insight into the effect of overexpression of Mst1 on the Hippo signaling in HepG2 cells, we examined the phosphorylation status of YAP, the activation of Mst1 and caspase-3 [ Fig. 3(A) ], and the expression of connective tissue growth factor (CTGF), amphiregulin (AREG), and birc5 (Survivin) (Fig. 6) . The catalytically active peptides of Mst1 [ Fig. 3(B) ] and caspase-3 proteins What's more, the relative transcript levels for CTGF, AREG, and Survivin were remarkably reduced in these cells (Fig. 6) . (Fig. 6) . These results indicated that overexpression of Mst1 promoted YAP phosphorylation and downregulated the expression of CTGF, AREG, and Survivin.
The relationship between the expression and activation of Mst1 and DDP-induced cell death Mst1 has also been involved in the death of cancer cells treated with anticancer drugs such as DDP, a broadspectrum anticancer and platinum-based DNA-damaging agent [29] . To investigate the relationship between the expression and cleavage of Mst1 and DDP anticancer effects, Fig. 7(B) ]. Therefore, it suggested that there is some relationship between the activation of Mst1 and DDP-induced cell death. Mst1 overexpression could increase the sensitivity to DDP and it could promote the activation of Mst1 protein in vitro.
Discussion
In this study, we successfully constructed the eukaryotic cell expression vector containing human wild type Mst1 gene and EGFP gene, and the Mst1 gene was successfully transfected into human HepG2 cells. We found that Mst1 overexpression could inhibit the growth of HepG2 cells, and this antiproliferation effect was associated with the induction of apoptosis. In addition, overexpression of Mst1 gene increased the sensitivity to DDP, and DDP could promote the activation of Mst1 protein, which may imply that there is some relationship between Mst1 and DDP during DDP-induced cell death. These results showed the prospects for Mst1 gene therapy in hepatocarcinoma treatment, also provided theoretical and experimental basis for Mst1 gene in clinical application, but specific mechanisms need to be further discussed. Moreover, it suggested that gene delivery to HepG2 cells may allow for new Mst1 overexpression effects the growth of HepG2 and the sensitivity to cisplatin therapeutic approaches to this life-threatening disease, and Mst1 may be as a potential therapeutic target for human tumors.
The transcriptional co-activator YAP is an evolutionarily conserved regulator of organ size and progenitor of cell proliferation [24] . Morin-Kensicki et al. [30] found homozygosity for the Yap tm1Smil allele (Yap 2/2 ) caused developmental arrest around E8.5. What's more, Mst1 and 2 acted in a redundant manner to maintain quiescence in the adult liver and that their dual inactivation led to immediate YAP1 nuclear residence and activation, liver overgrowth, resistance to Fas-induced apoptosis, and rapid HCC development, resulting from loss of YAP1 Ser127 phosphorylation [6] . Inactivation of Mst1 and 2 in liver was accompanied by expansion of both the hepatocytes and the bipotential adult liver progenitors, and characterized by many tumors with mixed cellularity, the loss of YAP1 (Ser127) phosphorylation and a marked increase in overall and nuclear YAP1 abundance [30, 31] . Moreover, Mst1 could restrain intestinal stem cell proliferation and colonic Mst1 overexpression effects the growth of HepG2 and the sensitivity to cisplatin tumorigenesis by inhibition of YAP overabundance [32] .
Here our data showed that overexpression of Mst1 inhibited cell proliferation, increased the apoptosis of HepG2 cells in vitro and promoted YAP Ser127 phosphorylation and caspase-3 activation. These findings indicated that Mst1 induced apoptosis may be through the phosphorylation of YAP1 (Ser127), which resulted in restraining its activity of promoting proliferation in mammalian HepG2 cells. In both the liver tumor nodules and pretumor mutant liver samples, Survivin mRNA expression was significantly upregulated [5] , and knockdown of YAP enhanced the sensitivity of cancer cells to the small-molecule antagonist of survivin, S12, a lead compound which can bind to survivin and exhibit promising biological activities [31] . Both CTGF and AREG have been identified as transcriptional targets of YAP required for cell growth and phenotypes [32, 33] . Mst1/2 null liver and HCC expressed substantial levels of CTGF [6] . Liu et al. [34] reported that Survivin was upregulated . 9 folds in savl mutant compared with wild type and .35 folds in tumor tissue, and similar observation was found for CTGF. Here, we found overexpression of Mst1 significantly reduced Survivin, CTGF, and AREG mRNA expression. These results further supported that Mst1 regulated Survivin, CTGF, and AREG expression via YAP (Ser127) phosphorylation.
Mst1 has an N-terminal catalytic domain and a C-terminal regulatory region. During apoptosis, the activation of caspase-3 usually results in Mst1 cleaved to remove the C-terminal regulatory domain and yield a catalytically active N-terminal peptide cleaved by caspase at DEMD 326 S and TMTD 349 G sites [35, 36] , which correlates with an increase in Mst1 activity. Exogenously expressed Mst1 could activate caspases that resulted in its cleavage [36] . Here we found that the level of Mst1 (CT) and caspase-3 (CL) were increasing followed by the elevated expression of fusion protein Mst1-EGFP in HepG2 cells in vitro. We concluded that Mst1 may be as both upstream and downstream factor of caspases, and there may be a crosstalk between Mst1 and caspase-mediated apoptotic signaling.
What's more, our data showed that Mst1 could enhance the sensitivity of HepG2 cells to DDP, and DDP could promote the cleavage of both endogenously and exogenously expressed Mst1 without affecting the expression of Mst1. Morinaka et al. [37] found that endogenous peroxiredoxin-I (PRX-I) was required for H 2 O 2 -induced Mst1 activation, and DDP treatment induced H 2 O 2 generation, which likewise caused PRX-I oligomer formation, Mst1 activation, and cell death. Moreover, studies found that Mst1 phosphorylated Sirtuin1 (Sirt1) and inhibited the deacetylation of Sirt1 that led to increasing the acetylation and Mst1 overexpression effects the growth of HepG2 and the sensitivity to cisplatin transactivation of p53 and inhibiting the interaction between Sirt1 and p53 [9] . In addition, in response to DNA damage, c-Abl was activated, bound to p73 via the SH3 domain and phosphorylated p73 (Tyr99) [38] , and also phosphorylated YAP1 (Tyr357). The phosphorylated YAP1 escaped the itch promoter-associated Runx [39] . YAP1 bound to p73 through its WW domain and the PPPY motif of p73, and promoted the transcriptional activity of p73 via the p300 acteyltansferase and the pro-myelocytic leukemia (PML) tumor-suppressor protein [40] [41] [42] , which resulted in the selective co-activation of the p73 pro-apoptotic targets, such as p53 regulated apoptosis inducing protein 1 (p53 AIP1), BCL2-associated X protein (Bax), and p53 inducible protein 3 (PIG3) [43] . In addition, YAP1 could stabilize p73 protein in a post-translational manner through competing with the itch E3-ligase for binding to p73, which allowed p73 to escape itch-mediated ubiquitination [44] . In summary, under DNA damage, YAP1 is a pro-apoptotic factor forming a complex with p73 and PML to regulate pro-apoptotic targets like p53 AIP1 and Bax. Therefore, it may imply that Figure 6 Quantitative RT-PCR analysis of MST1, CTGF, AREG, and Survivin mRNA expression in each group HepG2 cells *P , 0.05, **P , 0.01 vs. control or HepG2-vect; # P , 0.05 vs. HepG2-DDP; 4 P , 0.05, 44 P , 0.01 vs. HepG2-Mst1.
Mst1 overexpression effects the growth of HepG2 and the sensitivity to cisplatin there is probably some relationship among DDP, Mst1, YAP1, p53, and p73 during DDP-induced cell death (Fig. 8) .
Mst1 gene may be a useful candidate for the chemotherapy. However, additional studies exploring the in vivo biological activities of Mst1 are needed in the future, which will support Mst1 as a potential target for cancer therapy. Mst1 overexpression effects the growth of HepG2 and the sensitivity to cisplatin
